Type 2 Diabetes Treatment - Part 6 - SGLT2 Inhibitors - a podcast by Gil Porat, M.D., FACP, CPT

Sodium-Glucose Transporter 2 Inhibitors decrease glucose re-absorbtion. The diuretic effect, weight loss, DKA, cardiac outcomes, blood pressure, genital infections and a whole bunch of other information is discussed.

SGLT2s include Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance), Ertagliflozin (Steglatro), with more to be released in the future.

Further episodes of Hospital and Internal Medicine Podcast

Further podcasts by Gil Porat, M.D., FACP, CPT

Website of Gil Porat, M.D., FACP, CPT